THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;GENZYME CORPORATION
发明人:
Samuel Wadsworth,Abraham Scaria,Chi-Chao Chan
申请号：
US14785159
公开号：
US10640771B2
申请日:
2014.04.17
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Compositions and methods for treating macular degeneration are disclosed. The methods utilize IL17 inhibitors, such as IL17 receptors, as well as fusion proteins including an IL17 receptor fused with a multimerization domain, and recombinant viral vectors encoding such fusions.
